RT Journal Article
SR Electronic
T1 Safety of ‘hot’ and ‘cold’ site admissions within a high volume urology department in the United Kingdom at the peak of the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.04.20154203
DO 10.1101/2020.08.04.20154203
A1 Luke Stroman
A1 Beth Russell
A1 Pinky Kotecha
A1 Anastasia Kantartzi
A1 Luis Ribeiro
A1 Bethany Jackson
A1 Vugar Ismaylov
A1 Adeoye Oluwakanyinsola Debo-Aina
A1 Findlay MacAskill
A1 Francesca Kum
A1 Meghana Kulkarni
A1 Raveen Sandher
A1 Anna Walsh
A1 Ella Doerge
A1 Katherine Guest
A1 Yamini Kailash
A1 Nick Simson
A1 Cassandra McDonald
A1 Elsie Mensah
A1 Li June Tay
A1 Ramandeep Chalokia
A1 Sharon Clovis
A1 Elizabeth Eversden
A1 Jane Cossins
A1 Jonah Rusere
A1 Grace Zisengwe
A1 Louisa Fleure
A1 Leslie Cooper
A1 Kathryn Chatterton
A1 Amelia Barber
A1 Catherine Roberts
A1 Thomasia Azavedo
A1 Jeffrey Ritualo
A1 Harold Omana
A1 Liza Mills
A1 Lily Studd
A1 Oussama El Hage
A1 Rajesh Nair
A1 Sachin Malde
A1 Arun Sahai
A1 Archana Fernando
A1 Claire Taylor
A1 Benjamin Challacombe
A1 Ramesh Thurairaja
A1 Rick Popert
A1 Jonathon Olsburgh
A1 Paul Cathcart
A1 Christian Brown
A1 Marios Hadjipavlou
A1 Ella Di Benedetto
A1 Matthew Bultitude
A1 Jonathon Glass
A1 Tet Yap
A1 Rhana Zakri
A1 Majed Shabbir
A1 Susan Willis
A1 Kay Thomas
A1 Tim O’Brien
A1 Muhammad Shamim Khan
A1 Prokar Dasgupta
YR 2020
UL http://medrxiv.org/content/early/2020/08/06/2020.08.04.20154203.abstract
AB Background Contracting COVID-19 peri-operatively has been associated with a mortality rate as high as 23%, making prevention vital.Objectives The primary objective is to determine safety of surgical admissions and procedures during the height of the COVID-19 pandemic using ‘hot’ and ‘cold’ sites. The secondary objective is to determine risk factors of contracting COVID-19.Design, Setting and Participants A retrospective cohort study of all consecutive patients admitted from 1st March – 31st May 2020 at a high-volume tertiary urology department in London, United Kingdom. Elective surgery was carried out at a ‘cold’ site requiring a negative COVID-19 swab 72 hours prior to admission and to self-isolate for 14 days pre-operatively, whilst all acute admissions were admitted to the ‘hot’ site.Outcome Measurements and Statistical Analysis Complications related to COVID-19 were presented as percentages. Risk factors for developing COVID-19 infection were determined using multivariate logistic regression analysis.Results and Limitations A total of 611 patients, 451 (73.8%) male and 160 (26.2%) female, with a median age of 57 (interquartile range 44-70) were admitted under the urology team; 101 (16.5%) on the ‘cold’ site and 510 (83.5%) on the ‘hot’ site. Procedures were performed in 495 patients of which 8 (1.6%) contracted COVID-19 post-operatively with 1 (0.2%) post-operative mortality due to COVID-19. Overall, COVID-19 was detected in 20 (3.3%) patients with 2 (0.3%) deaths. Length of stay was associated with contracting COVID-19 in our cohort (OR 1.25, 95% CI 1.13-1.39). Limitations include possible under reporting due to post-operative patients presenting elsewhere.Conclusions Continuation of surgical procedures using ‘hot’ and ‘cold’ sites throughout the COVID-19 pandemic was safe practice, although the risk of COVID-19 remained and is underlined by a post-operative mortality.Patient Summary Using ‘hot’ and ‘cold’ sites has allowed the safe continuation of urological practice throughout the height of the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received towards this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This service evaluation/audit was granted institutional approval by the Guys and St Thomas Hospital and the requirement for consent for data use that was anonymised before analysis was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis service evaluation/audit was granted institutional approval by the Guys and St Thomas Hospital and the requirement for consent for data use that was anonymised before analysis was waived.